Literature DB >> 2929674

Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women.

F Kobayashi1, N Sagawa, K Nakamura, M Nonogaki, C Ban, S Fujii, T Mori.   

Abstract

To clarify the mechanism of CA 125 elevation in maternal sera, serum levels of CA 125 and CA 19-9 were measured in 122 apparently healthy pregnant women (fifth to fortieth week of gestation) and 50 postpartum women (26 term deliveries and 24 second-trimester induced abortions). Serum levels of CA 125 showed an initial increase by the tenth week and then decreased to less than 35 U/ml, remaining below this level until delivery. However, within 1 hour after term delivery or second-trimester induced abortion, the CA 125 levels showed a second increase and decreased rapidly thereafter. In contrast, serum levels of CA 19-9 did not change significantly during these periods. Combined with our previous finding that the decidua contains abundant CA 125 but little CA 19-9, these results indicate that the elevated CA 125 levels in maternal sera originate from the decidual cells affected by chorionic invasion or the placental separation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2929674     DOI: 10.1016/s0002-9378(89)80027-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective.

Authors:  Martina Montagnana; Marco Benati; Elisa Danese
Journal:  Ann Transl Med       Date:  2017-07

2.  Advanced epithelial ovarian carcinoma during pregnancy.

Authors:  Shin-ichi Ishioka; Takuhiro Hayashi; Toshiaki Endo; Tsuyoshi Baba; Hiroyuki Honma; Tsuyoshi Saito
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

3.  Measurement of HE4 and CA125 and establishment of reference intervals for the ROMA index in the sera of pregnant women.

Authors:  Jie Lu; Zhipeng Zheng; Qi Zhang; Guoli Li; Fengying Li; Zhian Le; Jun Huang; Xinyou Xie; Jun Zhang
Journal:  J Clin Lab Anal       Date:  2017-11-30       Impact factor: 2.352

4.  Maternal serum CA125 levels in early intrauterine and tubal pregnancies.

Authors:  F Kobayashi; E Takashima; N Sagawa; T Mori; S Fujii
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

Review 5.  Therapeutic management of epithelial ovarian cancer during pregnancy.

Authors:  L Minig; L Otaño; I Diaz-Padilla; R Alvarez Gallego; M G Patrono; J Valero de Bernabé
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

6.  Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review.

Authors:  Sileny N Han; Anouk Lotgerink; Mina Mhallem Gziri; Kristel Van Calsteren; Myriam Hanssens; Frédéric Amant
Journal:  BMC Med       Date:  2012-08-08       Impact factor: 8.775

7.  Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?

Authors:  O Kiekegaard; O Mogensen; B Mogensen; S Ahrons
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

8.  Metastatic Ovarian Clear Cell Carcinoma in the Context of In Vitro Fertilization Pregnancy.

Authors:  Arati Inamdar; Adriana Fulginiti; Shuk Fong Yiu; Abraham Loo; Brian Rogers; Robert Massaro; Robert A Graebe; Thomas E Hackett
Journal:  Case Rep Obstet Gynecol       Date:  2020-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.